Twelve Bio
Main focus: Treatment and diagnostics of genetic diseases
Company stage: Pre-clinical
Diseases: Undisclosed
Genome editing tool: CRISPR-Cas12a
Funding stage: Private
Location: Copenhagen, Denmark
Website: https://twelve.bio/
Twelve Bio is a pre-clinical stage gene-editing company that primarily focuses on the Cas12a enzyme. The company is located in Copenhagen, Denmark, as part of the Bioinnovation Institute accelerator, and has yet to disclose its first therapeutic programme.